We first examined the level of CD144 (vascular endothelial cadherin, VE-cadherin), a marker for endothelial gap junction, in circulating blood EVs, as disease-related endothelial dysfunction and a damage and chemotherapy-related complications monitoring tool. This evidence concerns the gene CDH5 and endothelial dysfunction.